

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 6.48559873 |
| 2 | rhodopsin mediated signaling pathway (GO:0016056) | 6.35932150 |
| 3 | retinal cone cell development (GO:0046549) | 4.97442598 |
| 4 | photoreceptor cell maintenance (GO:0045494) | 4.94115188 |
| 5 | photoreceptor cell development (GO:0042461) | 4.91218292 |
| 6 | retinal rod cell development (GO:0046548) | 4.75658712 |
| 7 | eye photoreceptor cell development (GO:0042462) | 4.67427262 |
| 8 | neural tube formation (GO:0001841) | 4.52925014 |
| 9 | regulation of meiosis I (GO:0060631) | 4.27580077 |
| 10 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.12993609 |
| 11 | detection of light stimulus involved in visual perception (GO:0050908) | 4.02738356 |
| 12 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.02738356 |
| 13 | limb bud formation (GO:0060174) | 3.99167479 |
| 14 | phototransduction (GO:0007602) | 3.89028589 |
| 15 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.79263932 |
| 16 | phototransduction, visible light (GO:0007603) | 3.78717225 |
| 17 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.76739051 |
| 18 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.76701476 |
| 19 | detection of light stimulus (GO:0009583) | 3.72490939 |
| 20 | detection of visible light (GO:0009584) | 3.63478081 |
| 21 | protein localization to synapse (GO:0035418) | 3.60028968 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.59841710 |
| 23 | sensory perception of smell (GO:0007608) | 3.52668777 |
| 24 | keratinocyte development (GO:0003334) | 3.51587667 |
| 25 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.50896503 |
| 26 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.48699638 |
| 27 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.48699638 |
| 28 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.48699638 |
| 29 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.48194018 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.44642801 |
| 31 | establishment of nucleus localization (GO:0040023) | 3.41019952 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.38918461 |
| 33 | glial cell proliferation (GO:0014009) | 3.35452091 |
| 34 | synaptic vesicle exocytosis (GO:0016079) | 3.34033860 |
| 35 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.30191797 |
| 36 | locomotory exploration behavior (GO:0035641) | 3.25770652 |
| 37 | visual perception (GO:0007601) | 3.23605034 |
| 38 | glutamate secretion (GO:0014047) | 3.21269898 |
| 39 | neuron cell-cell adhesion (GO:0007158) | 3.21058946 |
| 40 | sensory perception of light stimulus (GO:0050953) | 3.20339540 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.20246415 |
| 42 | photoreceptor cell differentiation (GO:0046530) | 3.20110701 |
| 43 | eye photoreceptor cell differentiation (GO:0001754) | 3.20110701 |
| 44 | DNA double-strand break processing (GO:0000729) | 3.19967621 |
| 45 | regulation of synaptic vesicle transport (GO:1902803) | 3.19361147 |
| 46 | vocalization behavior (GO:0071625) | 3.17331687 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.17161258 |
| 48 | inositol phosphate catabolic process (GO:0071545) | 3.15645393 |
| 49 | regulation of hexokinase activity (GO:1903299) | 3.15258245 |
| 50 | regulation of glucokinase activity (GO:0033131) | 3.15258245 |
| 51 | dendritic spine morphogenesis (GO:0060997) | 3.14486406 |
| 52 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.13692742 |
| 53 | regulation of protein glycosylation (GO:0060049) | 3.09834719 |
| 54 | intraciliary transport (GO:0042073) | 3.08784967 |
| 55 | behavioral response to cocaine (GO:0048148) | 3.05094406 |
| 56 | regulation of guanylate cyclase activity (GO:0031282) | 3.03252074 |
| 57 | lactate metabolic process (GO:0006089) | 3.03118229 |
| 58 | histone H2A acetylation (GO:0043968) | 3.03007968 |
| 59 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.02394658 |
| 60 | protein-chromophore linkage (GO:0018298) | 2.99703742 |
| 61 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.99540065 |
| 62 | neurotransmitter secretion (GO:0007269) | 2.99057705 |
| 63 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.98926439 |
| 64 | axoneme assembly (GO:0035082) | 2.96729187 |
| 65 | cellular potassium ion homeostasis (GO:0030007) | 2.95472397 |
| 66 | positive regulation of neurotransmitter transport (GO:0051590) | 2.93892492 |
| 67 | positive regulation of meiosis (GO:0045836) | 2.93538287 |
| 68 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.92112359 |
| 69 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.91960060 |
| 70 | sympathetic nervous system development (GO:0048485) | 2.89112726 |
| 71 | Golgi to endosome transport (GO:0006895) | 2.87507126 |
| 72 | nonmotile primary cilium assembly (GO:0035058) | 2.86769743 |
| 73 | auditory behavior (GO:0031223) | 2.86707954 |
| 74 | GMP metabolic process (GO:0046037) | 2.83340294 |
| 75 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.82743207 |
| 76 | response to pheromone (GO:0019236) | 2.82079038 |
| 77 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.81225016 |
| 78 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.81225016 |
| 79 | gamma-aminobutyric acid transport (GO:0015812) | 2.80921219 |
| 80 | response to histamine (GO:0034776) | 2.80338344 |
| 81 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.79467596 |
| 82 | mechanosensory behavior (GO:0007638) | 2.79145933 |
| 83 | detection of external stimulus (GO:0009581) | 2.74199548 |
| 84 | regulation of female receptivity (GO:0045924) | 2.73807358 |
| 85 | presynaptic membrane organization (GO:0097090) | 2.72848062 |
| 86 | negative regulation of dendrite development (GO:2000171) | 2.71677536 |
| 87 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.71289525 |
| 88 | neuronal action potential propagation (GO:0019227) | 2.71154327 |
| 89 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.70928563 |
| 90 | somite development (GO:0061053) | 2.70579188 |
| 91 | regulation of Rac protein signal transduction (GO:0035020) | 2.70390666 |
| 92 | branched-chain amino acid catabolic process (GO:0009083) | 2.69077589 |
| 93 | female mating behavior (GO:0060180) | 2.68328051 |
| 94 | protein K11-linked deubiquitination (GO:0035871) | 2.68173825 |
| 95 | regulation of development, heterochronic (GO:0040034) | 2.68151103 |
| 96 | detection of abiotic stimulus (GO:0009582) | 2.67369403 |
| 97 | positive regulation of meiotic cell cycle (GO:0051446) | 2.66842715 |
| 98 | sodium ion export (GO:0071436) | 2.66771217 |
| 99 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.66734196 |
| 100 | olfactory bulb development (GO:0021772) | 2.66541450 |
| 101 | regulation of timing of cell differentiation (GO:0048505) | 2.66449076 |
| 102 | activation of protein kinase A activity (GO:0034199) | 2.65951581 |
| 103 | long-term synaptic potentiation (GO:0060291) | 2.65733999 |
| 104 | detection of calcium ion (GO:0005513) | 2.64758275 |
| 105 | prostate gland growth (GO:0060736) | 2.64722072 |
| 106 | postsynaptic membrane organization (GO:0001941) | 2.64603584 |
| 107 | membrane hyperpolarization (GO:0060081) | 2.64548129 |
| 108 | behavioral response to ethanol (GO:0048149) | 2.64409873 |
| 109 | positive regulation of membrane potential (GO:0045838) | 2.63781383 |
| 110 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.62743088 |
| 111 | striatum development (GO:0021756) | 2.62025363 |
| 112 | polyol catabolic process (GO:0046174) | 2.61915099 |
| 113 | neuron-neuron synaptic transmission (GO:0007270) | 2.61410455 |
| 114 | neurotransmitter transport (GO:0006836) | 2.61253596 |
| 115 | embryonic epithelial tube formation (GO:0001838) | 2.59594532 |
| 116 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.59541193 |
| 117 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.59541193 |
| 118 | regulation of postsynaptic membrane potential (GO:0060078) | 2.58681721 |
| 119 | central nervous system neuron axonogenesis (GO:0021955) | 2.58663447 |
| 120 | regulation of neurotransmitter secretion (GO:0046928) | 2.58412688 |
| 121 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.58398001 |
| 122 | synapse assembly (GO:0007416) | 2.58201648 |
| 123 | kidney morphogenesis (GO:0060993) | 2.56942135 |
| 124 | piRNA metabolic process (GO:0034587) | 2.56745263 |
| 125 | negative regulation of activin receptor signaling pathway (GO:0032926) | 2.56435639 |
| 126 | establishment of protein localization to Golgi (GO:0072600) | 2.55137448 |
| 127 | L-fucose catabolic process (GO:0042355) | 2.54605997 |
| 128 | fucose catabolic process (GO:0019317) | 2.54605997 |
| 129 | L-fucose metabolic process (GO:0042354) | 2.54605997 |
| 130 | nucleobase catabolic process (GO:0046113) | 2.53929988 |
| 131 | inositol phosphate dephosphorylation (GO:0046855) | 2.53194193 |
| 132 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.53194193 |
| 133 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.52184635 |
| 134 | nucleus localization (GO:0051647) | 2.49996865 |
| 135 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.48842253 |
| 136 | negative regulation of protein oligomerization (GO:0032460) | 2.48338076 |
| 137 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.48061628 |
| 138 | gene silencing by RNA (GO:0031047) | 2.47408396 |
| 139 | positive regulation of glycolytic process (GO:0045821) | 2.47281957 |
| 140 | ether lipid metabolic process (GO:0046485) | 2.44506006 |
| 141 | potassium ion import (GO:0010107) | 2.44076726 |
| 142 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.43225360 |
| 143 | epithelial tube formation (GO:0072175) | 2.42964733 |
| 144 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.42719997 |
| 145 | reflex (GO:0060004) | 2.41847495 |
| 146 | regulation of collateral sprouting (GO:0048670) | 2.41545515 |
| 147 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.40676765 |
| 148 | synaptic transmission, glutamatergic (GO:0035249) | 2.40504442 |
| 149 | dentate gyrus development (GO:0021542) | 2.40174609 |
| 150 | head development (GO:0060322) | 2.39797636 |
| 151 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.38247505 |
| 152 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.37560224 |
| 153 | cell communication by electrical coupling (GO:0010644) | 2.36508833 |
| 154 | cerebellar granule cell differentiation (GO:0021707) | 2.36006115 |
| 155 | genitalia morphogenesis (GO:0035112) | 2.35735933 |
| 156 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.35242742 |
| 157 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.35062481 |
| 158 | regulation of dendritic spine development (GO:0060998) | 2.34037565 |
| 159 | regulation of neurotransmitter transport (GO:0051588) | 2.33600962 |
| 160 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.33461949 |
| 161 | glycosphingolipid biosynthetic process (GO:0006688) | 2.33268766 |
| 162 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.33174619 |
| 163 | C4-dicarboxylate transport (GO:0015740) | 2.32044794 |
| 164 | long-term memory (GO:0007616) | 2.31863553 |
| 165 | protein localization to cilium (GO:0061512) | 2.31803973 |
| 166 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.31616438 |
| 167 | regulation of alternative mRNA splicing, via spliceosome (GO:0000381) | 2.31558894 |
| 168 | protein prenylation (GO:0018342) | 2.31485608 |
| 169 | prenylation (GO:0097354) | 2.31485608 |
| 170 | sensory perception of chemical stimulus (GO:0007606) | 2.31026262 |
| 171 | negative regulation of cation channel activity (GO:2001258) | 2.30986170 |
| 172 | atrial cardiac muscle cell action potential (GO:0086014) | 2.30725958 |
| 173 | membrane depolarization during action potential (GO:0086010) | 2.30650475 |
| 174 | protein localization to Golgi apparatus (GO:0034067) | 2.30034454 |
| 175 | synaptic vesicle endocytosis (GO:0048488) | 2.28596887 |
| 176 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.28493882 |
| 177 | brain morphogenesis (GO:0048854) | 2.27853353 |
| 178 | peroxisome fission (GO:0016559) | 2.27092325 |
| 179 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.26932920 |
| 180 | positive regulation of muscle hypertrophy (GO:0014742) | 2.26932920 |
| 181 | innervation (GO:0060384) | 2.26850636 |
| 182 | protein targeting to Golgi (GO:0000042) | 2.26837115 |
| 183 | mating behavior (GO:0007617) | 2.26819828 |
| 184 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.26504160 |
| 185 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.26504160 |
| 186 | potassium ion homeostasis (GO:0055075) | 2.26335216 |
| 187 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.26119733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.83710639 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.36158187 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14260507 |
| 4 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.81706968 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.62183098 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.41189083 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.37346196 |
| 8 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.22043681 |
| 9 | EWS_26573619_Chip-Seq_HEK293_Human | 2.08043089 |
| 10 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.06996265 |
| 11 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.06996265 |
| 12 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.06204649 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.05919580 |
| 14 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05302216 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.04650690 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.00577214 |
| 17 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.99603664 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.98150960 |
| 19 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.96163091 |
| 20 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.92740401 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.86765538 |
| 22 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.85751732 |
| 23 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84899651 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.81968057 |
| 25 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.74685028 |
| 26 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.73491587 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.73442339 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.73045600 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72296423 |
| 30 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.71200076 |
| 31 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.68733184 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63178712 |
| 33 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61771192 |
| 34 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.59285405 |
| 35 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.58589742 |
| 36 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57707913 |
| 37 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.57582436 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57539058 |
| 39 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.56278788 |
| 40 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.56239848 |
| 41 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.56029348 |
| 42 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54293981 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53006465 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.48040930 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.45300577 |
| 46 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44454713 |
| 47 | P300_19829295_ChIP-Seq_ESCs_Human | 1.43367098 |
| 48 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43187482 |
| 49 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.41876887 |
| 50 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.41029830 |
| 51 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.39659526 |
| 52 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.34619929 |
| 53 | VDR_22108803_ChIP-Seq_LS180_Human | 1.34274253 |
| 54 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.31737527 |
| 55 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31422814 |
| 56 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31055330 |
| 57 | GATA1_22025678_ChIP-Seq_K562_Human | 1.30167875 |
| 58 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.29385909 |
| 59 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.28300024 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27926448 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.27757557 |
| 62 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27351979 |
| 63 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.27001706 |
| 64 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.26850807 |
| 65 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.26804838 |
| 66 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.26804838 |
| 67 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26764024 |
| 68 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.26208453 |
| 69 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.25288323 |
| 70 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.24885549 |
| 71 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24198066 |
| 72 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.24157289 |
| 73 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23335278 |
| 74 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.22980517 |
| 75 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.22931687 |
| 76 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22295202 |
| 77 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22208180 |
| 78 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.20766208 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.20458226 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.20458226 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.20147399 |
| 82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.20118987 |
| 83 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19523920 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.18914932 |
| 85 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18184995 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.17782967 |
| 87 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17474833 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.17237574 |
| 89 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17095055 |
| 90 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16572206 |
| 91 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16560430 |
| 92 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15893992 |
| 93 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.15890359 |
| 94 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.15129912 |
| 95 | AR_25329375_ChIP-Seq_VCAP_Human | 1.13316995 |
| 96 | * AR_19668381_ChIP-Seq_PC3_Human | 1.13144809 |
| 97 | * P300_18555785_Chip-Seq_ESCs_Mouse | 1.12253129 |
| 98 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.11858826 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.11718790 |
| 100 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.11557724 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10147079 |
| 102 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.09437602 |
| 103 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.07793674 |
| 104 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06654372 |
| 105 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06370644 |
| 106 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 1.04642616 |
| 107 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04461015 |
| 108 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04429584 |
| 109 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 1.04357040 |
| 110 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03046091 |
| 111 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03033212 |
| 112 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02477562 |
| 113 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02386640 |
| 114 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01943634 |
| 115 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.01904936 |
| 116 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.01572977 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.01091930 |
| 118 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.01084821 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.00470528 |
| 120 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.00222152 |
| 121 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.99666847 |
| 122 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99136558 |
| 123 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99082384 |
| 124 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.98506743 |
| 125 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98284542 |
| 126 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.97603551 |
| 127 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.97581205 |
| 128 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94334350 |
| 129 | FUS_26573619_Chip-Seq_HEK293_Human | 0.94290489 |
| 130 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.94059337 |
| 131 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.94005000 |
| 132 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.93994868 |
| 133 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93868881 |
| 134 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.93615800 |
| 135 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93205676 |
| 136 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.92273219 |
| 137 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92241860 |
| 138 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.89940332 |
| 139 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.89488737 |
| 140 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.89225385 |
| 141 | TP53_16413492_ChIP-PET_HCT116_Human | 0.88911403 |
| 142 | KDM2B_26808549_Chip-Seq_REH_Human | 0.88621910 |
| 143 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.87349845 |
| 144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86712470 |
| 145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86712470 |
| 146 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.86488582 |
| 147 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86363114 |
| 148 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86363114 |
| 149 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.86171586 |
| 150 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85765478 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005551_abnormal_eye_electrophysiolog | 5.27429255 |
| 2 | MP0003011_delayed_dark_adaptation | 4.22762002 |
| 3 | MP0006072_abnormal_retinal_apoptosis | 3.48374983 |
| 4 | MP0005253_abnormal_eye_physiology | 3.42108302 |
| 5 | MP0001984_abnormal_olfaction | 3.20866613 |
| 6 | MP0003880_abnormal_central_pattern | 3.16946960 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.05855303 |
| 8 | MP0008877_abnormal_DNA_methylation | 2.96593415 |
| 9 | MP0003122_maternal_imprinting | 2.71893608 |
| 10 | MP0009780_abnormal_chondrocyte_physiolo | 2.64717259 |
| 11 | MP0002102_abnormal_ear_morphology | 2.53917838 |
| 12 | MP0003635_abnormal_synaptic_transmissio | 2.50472506 |
| 13 | MP0002638_abnormal_pupillary_reflex | 2.39012022 |
| 14 | MP0004270_analgesia | 2.34864051 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.22177028 |
| 16 | MP0002822_catalepsy | 2.12462028 |
| 17 | MP0005423_abnormal_somatic_nervous | 2.12222727 |
| 18 | MP0003121_genomic_imprinting | 2.11418813 |
| 19 | MP0009745_abnormal_behavioral_response | 2.04023229 |
| 20 | MP0002064_seizures | 2.04014975 |
| 21 | MP0002090_abnormal_vision | 2.01206202 |
| 22 | MP0009046_muscle_twitch | 1.95603025 |
| 23 | MP0002063_abnormal_learning/memory/cond | 1.95257398 |
| 24 | MP0002837_dystrophic_cardiac_calcinosis | 1.95249617 |
| 25 | MP0002272_abnormal_nervous_system | 1.94687548 |
| 26 | MP0005646_abnormal_pituitary_gland | 1.91708207 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.89919521 |
| 28 | MP0005195_abnormal_posterior_eye | 1.89348627 |
| 29 | MP0002229_neurodegeneration | 1.87998687 |
| 30 | MP0002751_abnormal_autonomic_nervous | 1.85929654 |
| 31 | MP0001486_abnormal_startle_reflex | 1.80054850 |
| 32 | MP0002572_abnormal_emotion/affect_behav | 1.78773928 |
| 33 | MP0003890_abnormal_embryonic-extraembry | 1.77771432 |
| 34 | MP0005367_renal/urinary_system_phenotyp | 1.76615386 |
| 35 | MP0000516_abnormal_urinary_system | 1.76615386 |
| 36 | MP0001502_abnormal_circadian_rhythm | 1.71927656 |
| 37 | MP0001324_abnormal_eye_pigmentation | 1.71119811 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.69749079 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.60329297 |
| 40 | MP0008569_lethality_at_weaning | 1.58117834 |
| 41 | MP0005360_urolithiasis | 1.56898672 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.55539483 |
| 43 | MP0005075_abnormal_melanosome_morpholog | 1.54831666 |
| 44 | MP0004043_abnormal_pH_regulation | 1.52621440 |
| 45 | MP0001764_abnormal_homeostasis | 1.50787552 |
| 46 | MP0004145_abnormal_muscle_electrophysio | 1.50181292 |
| 47 | MP0002734_abnormal_mechanical_nocicepti | 1.48441061 |
| 48 | MP0002067_abnormal_sensory_capabilities | 1.47684606 |
| 49 | MP0001529_abnormal_vocalization | 1.46662059 |
| 50 | MP0001501_abnormal_sleep_pattern | 1.46087698 |
| 51 | MP0000427_abnormal_hair_cycle | 1.44696610 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.40743619 |
| 53 | MP0000013_abnormal_adipose_tissue | 1.39744713 |
| 54 | MP0000631_abnormal_neuroendocrine_gland | 1.38049594 |
| 55 | MP0002882_abnormal_neuron_morphology | 1.36097349 |
| 56 | MP0001177_atelectasis | 1.34687934 |
| 57 | MP0002139_abnormal_hepatobiliary_system | 1.32925888 |
| 58 | MP0004215_abnormal_myocardial_fiber | 1.31811401 |
| 59 | MP0005391_vision/eye_phenotype | 1.30790485 |
| 60 | MP0003329_amyloid_beta_deposits | 1.29097914 |
| 61 | MP0008875_abnormal_xenobiotic_pharmacok | 1.28635512 |
| 62 | MP0008995_early_reproductive_senescence | 1.27835782 |
| 63 | MP0001485_abnormal_pinna_reflex | 1.27043331 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.26973906 |
| 65 | MP0005365_abnormal_bile_salt | 1.25895470 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.25476916 |
| 67 | MP0002557_abnormal_social/conspecific_i | 1.25160921 |
| 68 | MP0010678_abnormal_skin_adnexa | 1.24699584 |
| 69 | MP0005379_endocrine/exocrine_gland_phen | 1.24178065 |
| 70 | MP0002752_abnormal_somatic_nervous | 1.22982209 |
| 71 | MP0003252_abnormal_bile_duct | 1.22503193 |
| 72 | MP0004924_abnormal_behavior | 1.20904246 |
| 73 | MP0005386_behavior/neurological_phenoty | 1.20904246 |
| 74 | MP0000383_abnormal_hair_follicle | 1.19710322 |
| 75 | MP0004885_abnormal_endolymph | 1.18475614 |
| 76 | MP0005085_abnormal_gallbladder_physiolo | 1.18459543 |
| 77 | MP0003787_abnormal_imprinting | 1.15805541 |
| 78 | MP0005394_taste/olfaction_phenotype | 1.15470879 |
| 79 | MP0005499_abnormal_olfactory_system | 1.15470879 |
| 80 | MP0004484_altered_response_of | 1.14366219 |
| 81 | MP0002233_abnormal_nose_morphology | 1.14223129 |
| 82 | MP0002736_abnormal_nociception_after | 1.13497640 |
| 83 | MP0002184_abnormal_innervation | 1.12840148 |
| 84 | MP0004085_abnormal_heartbeat | 1.09616178 |
| 85 | MP0005220_abnormal_exocrine_pancreas | 1.08429164 |
| 86 | MP0004130_abnormal_muscle_cell | 1.08088722 |
| 87 | MP0000647_abnormal_sebaceous_gland | 1.07852566 |
| 88 | MP0005535_abnormal_body_temperature | 1.07209931 |
| 89 | MP0003633_abnormal_nervous_system | 1.05524875 |
| 90 | MP0005248_abnormal_Harderian_gland | 1.04507113 |
| 91 | MP0000751_myopathy | 0.98108116 |
| 92 | MP0002234_abnormal_pharynx_morphology | 0.97859393 |
| 93 | MP0000613_abnormal_salivary_gland | 0.97054849 |
| 94 | MP0004036_abnormal_muscle_relaxation | 0.96649467 |
| 95 | MP0004147_increased_porphyrin_level | 0.96500039 |
| 96 | MP0003634_abnormal_glial_cell | 0.94828475 |
| 97 | MP0010386_abnormal_urinary_bladder | 0.94821118 |
| 98 | MP0006276_abnormal_autonomic_nervous | 0.94604591 |
| 99 | MP0004142_abnormal_muscle_tone | 0.94551405 |
| 100 | MP0003183_abnormal_peptide_metabolism | 0.94009317 |
| 101 | MP0001986_abnormal_taste_sensitivity | 0.93459706 |
| 102 | MP0003943_abnormal_hepatobiliary_system | 0.93117009 |
| 103 | MP0000639_abnormal_adrenal_gland | 0.91669378 |
| 104 | MP0003690_abnormal_glial_cell | 0.90170642 |
| 105 | MP0003879_abnormal_hair_cell | 0.89213747 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.89187471 |
| 107 | MP0010329_abnormal_lipoprotein_level | 0.88495430 |
| 108 | MP0008789_abnormal_olfactory_epithelium | 0.87875389 |
| 109 | MP0003937_abnormal_limbs/digits/tail_de | 0.86957408 |
| 110 | MP0003119_abnormal_digestive_system | 0.86811951 |
| 111 | MP0002066_abnormal_motor_capabilities/c | 0.86804773 |
| 112 | MP0003195_calcinosis | 0.86696398 |
| 113 | MP0001970_abnormal_pain_threshold | 0.85855241 |
| 114 | MP0002254_reproductive_system_inflammat | 0.83155732 |
| 115 | MP0010234_abnormal_vibrissa_follicle | 0.82828053 |
| 116 | MP0000778_abnormal_nervous_system | 0.82376307 |
| 117 | MP0002876_abnormal_thyroid_physiology | 0.81728314 |
| 118 | MP0005620_abnormal_muscle_contractility | 0.80984333 |
| 119 | MP0009384_cardiac_valve_regurgitation | 0.80470212 |
| 120 | MP0008961_abnormal_basal_metabolism | 0.80300187 |
| 121 | MP0001188_hyperpigmentation | 0.79526689 |
| 122 | MP0004811_abnormal_neuron_physiology | 0.78907468 |
| 123 | MP0002127_abnormal_cardiovascular_syste | 0.78895108 |
| 124 | MP0005187_abnormal_penis_morphology | 0.78406765 |
| 125 | MP0004133_heterotaxia | 0.77581640 |
| 126 | MP0002735_abnormal_chemical_nociception | 0.76934326 |
| 127 | MP0002938_white_spotting | 0.76775296 |
| 128 | MP0001944_abnormal_pancreas_morphology | 0.76382132 |
| 129 | MP0000955_abnormal_spinal_cord | 0.74753989 |
| 130 | MP0000230_abnormal_systemic_arterial | 0.74141722 |
| 131 | MP0003935_abnormal_craniofacial_develop | 0.74125322 |
| 132 | MP0002733_abnormal_thermal_nociception | 0.73857696 |
| 133 | MP0002078_abnormal_glucose_homeostasis | 0.72997077 |
| 134 | MP0002009_preneoplasia | 0.72819229 |
| 135 | MP0003698_abnormal_male_reproductive | 0.72807202 |
| 136 | MP0003938_abnormal_ear_development | 0.72338550 |
| 137 | MP0003631_nervous_system_phenotype | 0.72047596 |
| 138 | MP0002282_abnormal_trachea_morphology | 0.71955653 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.71823558 |
| 140 | MP0002332_abnormal_exercise_endurance | 0.71651288 |
| 141 | MP0008872_abnormal_physiological_respon | 0.71055484 |
| 142 | MP0004084_abnormal_cardiac_muscle | 0.68715740 |
| 143 | MP0003137_abnormal_impulse_conducting | 0.68507625 |
| 144 | MP0004233_abnormal_muscle_weight | 0.67027367 |
| 145 | MP0002160_abnormal_reproductive_system | 0.66484538 |
| 146 | MP0000653_abnormal_sex_gland | 0.66027251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 8.49383543 |
| 2 | Bony spicule pigmentary retinopathy (HP:0007737) | 7.90945354 |
| 3 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.28235536 |
| 4 | Central scotoma (HP:0000603) | 6.27808152 |
| 5 | Chorioretinal atrophy (HP:0000533) | 6.09000170 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.96609223 |
| 7 | Pigmentary retinal degeneration (HP:0001146) | 5.74798496 |
| 8 | Abnormality of macular pigmentation (HP:0008002) | 5.33694797 |
| 9 | Scotoma (HP:0000575) | 5.00862443 |
| 10 | Abolished electroretinogram (ERG) (HP:0000550) | 4.67715372 |
| 11 | Attenuation of retinal blood vessels (HP:0007843) | 4.40710687 |
| 12 | Dyschromatopsia (HP:0007641) | 4.20007543 |
| 13 | Type II diabetes mellitus (HP:0005978) | 3.83566714 |
| 14 | Pendular nystagmus (HP:0012043) | 3.76977186 |
| 15 | Focal motor seizures (HP:0011153) | 3.59861441 |
| 16 | Decreased central vision (HP:0007663) | 3.59829249 |
| 17 | Retinitis pigmentosa (HP:0000510) | 3.51862512 |
| 18 | Febrile seizures (HP:0002373) | 3.40913052 |
| 19 | Photophobia (HP:0000613) | 3.38103330 |
| 20 | Visual hallucinations (HP:0002367) | 3.22152652 |
| 21 | Atonic seizures (HP:0010819) | 3.15973659 |
| 22 | Epileptic encephalopathy (HP:0200134) | 3.13013090 |
| 23 | Choroideremia (HP:0001139) | 3.04123510 |
| 24 | Gait imbalance (HP:0002141) | 3.03136242 |
| 25 | Aqueductal stenosis (HP:0002410) | 2.94101980 |
| 26 | Constricted visual fields (HP:0001133) | 2.93112168 |
| 27 | Congenital primary aphakia (HP:0007707) | 2.91947404 |
| 28 | Macular degeneration (HP:0000608) | 2.90598171 |
| 29 | Cone-rod dystrophy (HP:0000548) | 2.89565799 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 2.89478141 |
| 31 | Abnormality of the labia minora (HP:0012880) | 2.89436578 |
| 32 | Posterior subcapsular cataract (HP:0007787) | 2.85133092 |
| 33 | Increased corneal curvature (HP:0100692) | 2.83813987 |
| 34 | Keratoconus (HP:0000563) | 2.83813987 |
| 35 | Focal seizures (HP:0007359) | 2.82039868 |
| 36 | Volvulus (HP:0002580) | 2.81399548 |
| 37 | Abnormality of the astrocytes (HP:0100707) | 2.80301686 |
| 38 | Astrocytoma (HP:0009592) | 2.80301686 |
| 39 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.79735936 |
| 40 | Ependymoma (HP:0002888) | 2.77053765 |
| 41 | Intestinal atresia (HP:0011100) | 2.72064768 |
| 42 | Pancreatic cysts (HP:0001737) | 2.71793405 |
| 43 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.68981126 |
| 44 | Nephrogenic diabetes insipidus (HP:0009806) | 2.68097993 |
| 45 | Vitreoretinal degeneration (HP:0000655) | 2.65274663 |
| 46 | Progressive inability to walk (HP:0002505) | 2.61790816 |
| 47 | Glioma (HP:0009733) | 2.61214245 |
| 48 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.60836315 |
| 49 | True hermaphroditism (HP:0010459) | 2.55722192 |
| 50 | Hepatoblastoma (HP:0002884) | 2.55610433 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.52116724 |
| 52 | Thyroid carcinoma (HP:0002890) | 2.51102214 |
| 53 | Hyperventilation (HP:0002883) | 2.51048637 |
| 54 | Hypoglycemic coma (HP:0001325) | 2.50192031 |
| 55 | Retinal atrophy (HP:0001105) | 2.49162954 |
| 56 | Papillary thyroid carcinoma (HP:0002895) | 2.47751159 |
| 57 | Abnormality of the renal cortex (HP:0011035) | 2.45697328 |
| 58 | Exercise-induced myalgia (HP:0003738) | 2.45481769 |
| 59 | Neoplasm of the oral cavity (HP:0100649) | 2.45074685 |
| 60 | Pancreatic fibrosis (HP:0100732) | 2.44558006 |
| 61 | Renal cortical cysts (HP:0000803) | 2.43208850 |
| 62 | Absence seizures (HP:0002121) | 2.41883694 |
| 63 | Dysdiadochokinesis (HP:0002075) | 2.41805576 |
| 64 | Thyroiditis (HP:0100646) | 2.41425967 |
| 65 | Progressive visual loss (HP:0000529) | 2.34590752 |
| 66 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.32472689 |
| 67 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.32472689 |
| 68 | Severe visual impairment (HP:0001141) | 2.27723038 |
| 69 | Truncal ataxia (HP:0002078) | 2.27714506 |
| 70 | Neoplasm of the adrenal cortex (HP:0100641) | 2.27692791 |
| 71 | Inability to walk (HP:0002540) | 2.27388175 |
| 72 | Gaze-evoked nystagmus (HP:0000640) | 2.23218226 |
| 73 | Myokymia (HP:0002411) | 2.23074984 |
| 74 | Genital tract atresia (HP:0001827) | 2.22803833 |
| 75 | Methylmalonic acidemia (HP:0002912) | 2.21250966 |
| 76 | Nephronophthisis (HP:0000090) | 2.21227303 |
| 77 | Generalized tonic-clonic seizures (HP:0002069) | 2.20693030 |
| 78 | Optic disc pallor (HP:0000543) | 2.20385645 |
| 79 | Poor coordination (HP:0002370) | 2.18992151 |
| 80 | Vaginal atresia (HP:0000148) | 2.18523612 |
| 81 | Pheochromocytoma (HP:0002666) | 2.17873860 |
| 82 | Long clavicles (HP:0000890) | 2.16948834 |
| 83 | Renal hypoplasia (HP:0000089) | 2.15980130 |
| 84 | Abnormality of the parathyroid morphology (HP:0011766) | 2.14749338 |
| 85 | Stomach cancer (HP:0012126) | 2.11105024 |
| 86 | Anxiety (HP:0000739) | 2.08123582 |
| 87 | Dialeptic seizures (HP:0011146) | 2.06371696 |
| 88 | Ketoacidosis (HP:0001993) | 2.05555004 |
| 89 | Depression (HP:0000716) | 2.03532719 |
| 90 | Dysmetric saccades (HP:0000641) | 2.02199312 |
| 91 | Postaxial hand polydactyly (HP:0001162) | 2.01176416 |
| 92 | Widely spaced teeth (HP:0000687) | 2.00969607 |
| 93 | Absent speech (HP:0001344) | 2.00505008 |
| 94 | Abnormality of the renal medulla (HP:0100957) | 1.98205311 |
| 95 | Neuroendocrine neoplasm (HP:0100634) | 1.97060522 |
| 96 | Scanning speech (HP:0002168) | 1.96516491 |
| 97 | Action tremor (HP:0002345) | 1.96170681 |
| 98 | Broad-based gait (HP:0002136) | 1.95815726 |
| 99 | Broad alveolar ridges (HP:0000187) | 1.95628724 |
| 100 | Abnormality of the pubic bones (HP:0003172) | 1.95231986 |
| 101 | Hypsarrhythmia (HP:0002521) | 1.94664893 |
| 102 | Cupped ear (HP:0000378) | 1.90899283 |
| 103 | Hip dysplasia (HP:0001385) | 1.88139161 |
| 104 | Lissencephaly (HP:0001339) | 1.87263354 |
| 105 | Macroorchidism (HP:0000053) | 1.85017834 |
| 106 | Abnormality of midbrain morphology (HP:0002418) | 1.84840472 |
| 107 | Molar tooth sign on MRI (HP:0002419) | 1.84840472 |
| 108 | Absent eyebrow (HP:0002223) | 1.84689822 |
| 109 | Hyperglycemia (HP:0003074) | 1.84144945 |
| 110 | Hamartoma of the eye (HP:0010568) | 1.82964875 |
| 111 | Muscular hypotonia of the trunk (HP:0008936) | 1.82799478 |
| 112 | EEG with generalized epileptiform discharges (HP:0011198) | 1.82754529 |
| 113 | Colon cancer (HP:0003003) | 1.80825139 |
| 114 | Megalencephaly (HP:0001355) | 1.80443132 |
| 115 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.80036530 |
| 116 | Congenital malformation of the right heart (HP:0011723) | 1.79913557 |
| 117 | Double outlet right ventricle (HP:0001719) | 1.79913557 |
| 118 | Gonadotropin excess (HP:0000837) | 1.79818685 |
| 119 | Biliary tract neoplasm (HP:0100574) | 1.79480413 |
| 120 | Narrow forehead (HP:0000341) | 1.79472498 |
| 121 | Genetic anticipation (HP:0003743) | 1.79468527 |
| 122 | Scrotal hypoplasia (HP:0000046) | 1.79446195 |
| 123 | Hemiparesis (HP:0001269) | 1.79433182 |
| 124 | Exotropia (HP:0000577) | 1.79423128 |
| 125 | Limb dystonia (HP:0002451) | 1.79189201 |
| 126 | Rhabdomyosarcoma (HP:0002859) | 1.79057800 |
| 127 | Amyotrophic lateral sclerosis (HP:0007354) | 1.78875920 |
| 128 | Tubulointerstitial nephritis (HP:0001970) | 1.78495043 |
| 129 | Blue irides (HP:0000635) | 1.77433621 |
| 130 | Breast carcinoma (HP:0003002) | 1.76654826 |
| 131 | Left ventricular hypertrophy (HP:0001712) | 1.74870263 |
| 132 | Epileptiform EEG discharges (HP:0011182) | 1.74831236 |
| 133 | Abnormality of vitamin B metabolism (HP:0004340) | 1.74720885 |
| 134 | Subcapsular cataract (HP:0000523) | 1.73938963 |
| 135 | Neoplasm of the adrenal gland (HP:0100631) | 1.73729858 |
| 136 | Intention tremor (HP:0002080) | 1.73027966 |
| 137 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.72201000 |
| 138 | Fair hair (HP:0002286) | 1.72078153 |
| 139 | Agitation (HP:0000713) | 1.71991625 |
| 140 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.71858961 |
| 141 | Medulloblastoma (HP:0002885) | 1.71323637 |
| 142 | Specific learning disability (HP:0001328) | 1.70922653 |
| 143 | Prolonged QT interval (HP:0001657) | 1.69405362 |
| 144 | Postaxial foot polydactyly (HP:0001830) | 1.69207997 |
| 145 | Wide nasal bridge (HP:0000431) | 1.69132679 |
| 146 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.69038804 |
| 147 | Pachygyria (HP:0001302) | 1.67383999 |
| 148 | Long nose (HP:0003189) | 1.65547905 |
| 149 | Hypothermia (HP:0002045) | 1.65518112 |
| 150 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.65428047 |
| 151 | Dysmetria (HP:0001310) | 1.65256412 |
| 152 | Thin upper lip vermilion (HP:0000219) | 1.64688814 |
| 153 | Ketosis (HP:0001946) | 1.63743721 |
| 154 | Bifid tongue (HP:0010297) | 1.63000412 |
| 155 | Postural instability (HP:0002172) | 1.62260671 |
| 156 | Syncope (HP:0001279) | 1.61625454 |
| 157 | Status epilepticus (HP:0002133) | 1.61154046 |
| 158 | Calf muscle hypertrophy (HP:0008981) | 1.58250207 |
| 159 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.58145017 |
| 160 | Supranuclear gaze palsy (HP:0000605) | 1.56774194 |
| 161 | Exercise-induced muscle cramps (HP:0003710) | 1.54971900 |
| 162 | Impaired smooth pursuit (HP:0007772) | 1.53294610 |
| 163 | Hyperlipoproteinemia (HP:0010980) | 1.52882619 |
| 164 | Retinal dysplasia (HP:0007973) | 1.52030230 |
| 165 | Drooling (HP:0002307) | 1.51256125 |
| 166 | Excessive salivation (HP:0003781) | 1.51256125 |
| 167 | Abnormal gallbladder physiology (HP:0012438) | 1.50483209 |
| 168 | Cholecystitis (HP:0001082) | 1.50483209 |
| 169 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.49722167 |
| 170 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.49722167 |
| 171 | Congenital sensorineural hearing impairment (HP:0008527) | 1.49179335 |
| 172 | Abnormal social behavior (HP:0012433) | 1.48819310 |
| 173 | Impaired social interactions (HP:0000735) | 1.48819310 |
| 174 | Lower limb muscle weakness (HP:0007340) | 1.48463005 |
| 175 | Hypoglycemic seizures (HP:0002173) | 1.48147726 |
| 176 | Abnormality of the corticospinal tract (HP:0002492) | 1.47713285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GRK1 | 3.07577772 |
| 2 | TRIM28 | 2.89379999 |
| 3 | MAP3K4 | 2.67229615 |
| 4 | CASK | 2.66607514 |
| 5 | EPHA4 | 2.48178971 |
| 6 | BCR | 2.36559106 |
| 7 | NTRK3 | 2.35016577 |
| 8 | MAP2K7 | 2.26456447 |
| 9 | PINK1 | 2.26234497 |
| 10 | MAP4K2 | 2.24274084 |
| 11 | INSRR | 2.21844082 |
| 12 | DAPK2 | 2.06579270 |
| 13 | ACVR1B | 1.99502282 |
| 14 | MAP2K4 | 1.92340862 |
| 15 | MKNK2 | 1.89959435 |
| 16 | EIF2AK3 | 1.80185646 |
| 17 | NUAK1 | 1.68633860 |
| 18 | SGK494 | 1.64324303 |
| 19 | SGK223 | 1.64324303 |
| 20 | PRPF4B | 1.62488786 |
| 21 | PHKG1 | 1.57534289 |
| 22 | PHKG2 | 1.57534289 |
| 23 | SGK2 | 1.55842348 |
| 24 | MAP3K9 | 1.55717394 |
| 25 | ERBB3 | 1.55072450 |
| 26 | STK38 | 1.52041162 |
| 27 | FRK | 1.51804376 |
| 28 | MAP3K2 | 1.41189440 |
| 29 | PNCK | 1.37824997 |
| 30 | PRKCH | 1.37677861 |
| 31 | NTRK2 | 1.36924268 |
| 32 | OXSR1 | 1.31752065 |
| 33 | PAK6 | 1.31194335 |
| 34 | MKNK1 | 1.29473410 |
| 35 | FGFR3 | 1.28659686 |
| 36 | SGK3 | 1.25351887 |
| 37 | MAPK12 | 1.24459257 |
| 38 | BRD4 | 1.23450437 |
| 39 | YES1 | 1.22044443 |
| 40 | MAPK15 | 1.21921343 |
| 41 | PAK3 | 1.21641231 |
| 42 | SIK2 | 1.21598247 |
| 43 | FGFR2 | 1.21025602 |
| 44 | MINK1 | 1.20607943 |
| 45 | MAPK7 | 1.18333633 |
| 46 | MYLK | 1.17157130 |
| 47 | WNK4 | 1.15874104 |
| 48 | STK38L | 1.12892072 |
| 49 | CAMKK1 | 1.11899284 |
| 50 | BMPR2 | 1.11409203 |
| 51 | CDK3 | 1.10773093 |
| 52 | MAP3K12 | 1.08783383 |
| 53 | AKT3 | 1.08045960 |
| 54 | HIPK2 | 1.06512760 |
| 55 | WNK1 | 1.05721540 |
| 56 | WNK3 | 1.05097988 |
| 57 | CDK19 | 1.04563253 |
| 58 | CDK5 | 1.04256800 |
| 59 | MARK1 | 1.03142357 |
| 60 | PRKD3 | 1.01881750 |
| 61 | CAMKK2 | 1.01399763 |
| 62 | STK39 | 1.00743099 |
| 63 | GRK5 | 0.99248269 |
| 64 | RPS6KA4 | 0.97092435 |
| 65 | TGFBR1 | 0.96505444 |
| 66 | TNIK | 0.95316977 |
| 67 | PRKCG | 0.94795554 |
| 68 | PLK2 | 0.93514467 |
| 69 | STK24 | 0.93450985 |
| 70 | MAP3K7 | 0.93429281 |
| 71 | NEK6 | 0.93151658 |
| 72 | IRAK2 | 0.92875759 |
| 73 | CSNK1G1 | 0.89919451 |
| 74 | CAMK2A | 0.88811639 |
| 75 | MAP3K13 | 0.88051912 |
| 76 | PLK3 | 0.87676941 |
| 77 | BMPR1B | 0.87488981 |
| 78 | BRSK2 | 0.86078547 |
| 79 | MAPK13 | 0.84778287 |
| 80 | NLK | 0.83903383 |
| 81 | DYRK1A | 0.80972610 |
| 82 | NTRK1 | 0.80669093 |
| 83 | CAMK2D | 0.79953740 |
| 84 | PDK2 | 0.79391596 |
| 85 | CAMK2B | 0.77447392 |
| 86 | RET | 0.77240110 |
| 87 | SIK3 | 0.77173410 |
| 88 | KSR2 | 0.76814161 |
| 89 | EIF2AK1 | 0.75871880 |
| 90 | CAMK1 | 0.75750851 |
| 91 | LATS1 | 0.74897710 |
| 92 | PRKCE | 0.72658284 |
| 93 | SRPK1 | 0.71493534 |
| 94 | CAMK2G | 0.68261268 |
| 95 | MARK2 | 0.68120875 |
| 96 | PRKD2 | 0.67170138 |
| 97 | FES | 0.66926850 |
| 98 | PASK | 0.66011847 |
| 99 | TNK2 | 0.65216355 |
| 100 | FGFR1 | 0.65172261 |
| 101 | CAMK1G | 0.64786302 |
| 102 | CSNK1G2 | 0.63030932 |
| 103 | MST4 | 0.62743254 |
| 104 | UHMK1 | 0.62127731 |
| 105 | SGK1 | 0.62118093 |
| 106 | DAPK1 | 0.59690124 |
| 107 | CSNK1G3 | 0.58963222 |
| 108 | FER | 0.58086302 |
| 109 | CSNK1A1L | 0.57982668 |
| 110 | PIK3CA | 0.56529837 |
| 111 | PRKAA1 | 0.56030146 |
| 112 | ARAF | 0.55908534 |
| 113 | PIK3CG | 0.55141754 |
| 114 | TAOK3 | 0.55005533 |
| 115 | RPS6KA2 | 0.53554249 |
| 116 | DYRK2 | 0.53407565 |
| 117 | STK11 | 0.53067146 |
| 118 | EPHA3 | 0.52596905 |
| 119 | TYRO3 | 0.52094048 |
| 120 | PDK1 | 0.52054623 |
| 121 | RPS6KA3 | 0.51942442 |
| 122 | KSR1 | 0.51170301 |
| 123 | ADRBK1 | 0.50770266 |
| 124 | ERBB2 | 0.50301879 |
| 125 | ADRBK2 | 0.49884746 |
| 126 | MAPKAPK5 | 0.49793732 |
| 127 | OBSCN | 0.48065656 |
| 128 | PDPK1 | 0.47620526 |
| 129 | STK3 | 0.46995033 |
| 130 | PRKAA2 | 0.45810605 |
| 131 | TEC | 0.45463784 |
| 132 | PRKACA | 0.45423917 |
| 133 | CAMK4 | 0.45268653 |
| 134 | PRKCZ | 0.44134138 |
| 135 | MAP3K6 | 0.44129385 |
| 136 | CSNK1D | 0.44095902 |
| 137 | PRKD1 | 0.44079771 |
| 138 | FYN | 0.44055058 |
| 139 | RPS6KB1 | 0.37616757 |
| 140 | ATM | 0.36806366 |
| 141 | EGFR | 0.35171701 |
| 142 | PRKG1 | 0.33909700 |
| 143 | DYRK3 | 0.31905188 |
| 144 | MUSK | 0.28180537 |
| 145 | CLK1 | 0.25121206 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 7.63721426 |
| 2 | Olfactory transduction_Homo sapiens_hsa04740 | 2.92006048 |
| 3 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.40337474 |
| 4 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.34922084 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.25571175 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.25004000 |
| 7 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.16417201 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.11952653 |
| 9 | Nicotine addiction_Homo sapiens_hsa05033 | 2.01890987 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87831269 |
| 11 | Morphine addiction_Homo sapiens_hsa05032 | 1.87173256 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.82399340 |
| 13 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.75017394 |
| 14 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.70612834 |
| 15 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.60364570 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 1.59813284 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.54299460 |
| 18 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.49430478 |
| 19 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.49360627 |
| 20 | Basal transcription factors_Homo sapiens_hsa03022 | 1.45948680 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.37222913 |
| 22 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.36897495 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.35331490 |
| 24 | Salivary secretion_Homo sapiens_hsa04970 | 1.34200615 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32537164 |
| 26 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.30791230 |
| 27 | Taste transduction_Homo sapiens_hsa04742 | 1.29984373 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.29722836 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.26866028 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.24952566 |
| 31 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24917353 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.22403027 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.21667912 |
| 34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.20901222 |
| 35 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.16589020 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.15409824 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15363324 |
| 38 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.12875270 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.10728662 |
| 40 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.10329800 |
| 41 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.09513663 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.06378978 |
| 43 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.05052500 |
| 44 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.04373635 |
| 45 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.02257811 |
| 46 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.99073383 |
| 47 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.98777810 |
| 48 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.98580493 |
| 49 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.98487742 |
| 50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.97730989 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.96696438 |
| 52 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.96386654 |
| 53 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96371402 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.96093187 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.95457149 |
| 56 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95385140 |
| 57 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.94418549 |
| 58 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93863300 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93734384 |
| 60 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.93241478 |
| 61 | Bile secretion_Homo sapiens_hsa04976 | 0.92272784 |
| 62 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91469350 |
| 63 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.89566165 |
| 64 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89038914 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.85161143 |
| 66 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84426380 |
| 67 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.84004154 |
| 68 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.77449566 |
| 69 | ABC transporters_Homo sapiens_hsa02010 | 0.76302215 |
| 70 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.75007891 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.72943485 |
| 72 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72940444 |
| 73 | Long-term depression_Homo sapiens_hsa04730 | 0.71702109 |
| 74 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.70628611 |
| 75 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.70509127 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.70155231 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67332091 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.67311359 |
| 79 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.66627685 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.66214320 |
| 81 | Axon guidance_Homo sapiens_hsa04360 | 0.66050041 |
| 82 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65810640 |
| 83 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.65386073 |
| 84 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63767304 |
| 85 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.63332494 |
| 86 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61760646 |
| 87 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.61691789 |
| 88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61576261 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61497053 |
| 90 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61145028 |
| 91 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.59439583 |
| 92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58396958 |
| 93 | Gap junction_Homo sapiens_hsa04540 | 0.58036392 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56386712 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56218383 |
| 96 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.56031669 |
| 97 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55809444 |
| 98 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.55347539 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55175182 |
| 100 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.54755601 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.54676376 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.53279062 |
| 103 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.53220668 |
| 104 | Lysine degradation_Homo sapiens_hsa00310 | 0.52275129 |
| 105 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.50712873 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50567723 |
| 107 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49713306 |
| 108 | Peroxisome_Homo sapiens_hsa04146 | 0.49631473 |
| 109 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47841108 |
| 110 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46856476 |
| 111 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46770068 |
| 112 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.46437231 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.45560021 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44763307 |
| 115 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44667565 |
| 116 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43933581 |
| 117 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.43881690 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43731314 |
| 119 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.42716811 |
| 120 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42557151 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42334127 |
| 122 | Melanogenesis_Homo sapiens_hsa04916 | 0.42233676 |
| 123 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.42150110 |
| 124 | Tight junction_Homo sapiens_hsa04530 | 0.41595456 |
| 125 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41343197 |
| 126 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.40690881 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.40487181 |
| 128 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40384721 |
| 129 | Glioma_Homo sapiens_hsa05214 | 0.36094333 |
| 130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35766223 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.35612316 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.35029529 |
| 133 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34949705 |
| 134 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34564534 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.33743352 |
| 136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33112698 |
| 137 | Alzheimers disease_Homo sapiens_hsa05010 | 0.31816047 |
| 138 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31489113 |
| 139 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30170135 |

